Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Cardiovascular Risk and Comorbidity Management Blood Pressure Both Guidelines Individualise BP targets
11, 2024 GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death in adults who had an initial stroke, according to a preliminary study to be presented at the American Heart Associations Scientific Sessions 2024
Starting at a higher dose is technically off-label but is commonly used in specialist obesity practice when switching from another GLP-1 medication
However, intermittent arrhythmias may not be captured during a routine ECG
